High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

M. Nickelsen1* M. Ziepert2 S. Zeynalova2 B. Glass1 B. Metzner3 M. Leithaeuser4 H. K. Mueller-Hermelink5 M. Pfreundschuh6 and N. Schmitz1

首页> 外文期刊>Annals of Oncology >High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

【24h】

High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

机译：T细胞淋巴瘤中的大剂量CHOP加依托泊苷（MegaCHOEP）：在德国高级别非霍奇金淋巴瘤研究组（DSHNHL）的试验中对患者进行的比较分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: T-cell lymphomas (T-NHL) generally carry a poor prognosis. High-dose therapy (HDT) and autologous stem cell transplantation (ASCT) are increasingly used to treat younger patients.

机译：背景：T细胞淋巴瘤（T-NHL）通常预后较差。大剂量疗法（HDT）和自体干细胞移植（ASCT）越来越多地用于治疗年轻患者。

著录项

来源
《Annals of Oncology 》 |2009年第12期| p.1977-1984| 共8页
作者
M. Nickelsen1* M. Ziepert2 S. Zeynalova2 B. Glass1 B. Metzner3 M. Leithaeuser4 H. K. Mueller-Hermelink5 M. Pfreundschuh6 and N. Schmitz1;
展开▼
作者单位

1Department of Hematology and Stem Cell Transplantation, Asklepios Hospital St Georg, Hamburg 2Institute of Medical Informatics, Statistics and Epidemiology, University of Leipzig 3Clinic for Oncology and Hematology, Klinikum Oldenburg 4Department of Hematology and Oncology, University of Rostock 5Institute of Pathology, University of Wuerzburg 6Department of Internal Medicine I, Saarland University, Homburg/Saar, Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). [J] . Nickelsen M, Ziepert M, Zeynalova Annals of oncology: official journal of the European Society for Medical Oncology . 2009 ,第12期

机译：T细胞淋巴瘤中的大剂量CHOP加依托泊苷（MegaCHOEP）：在德国高级别非霍奇金淋巴瘤研究组（DSHNHL）的试验中对治疗的患者进行比较分析。
2. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). [J] . Boehme V, Schmitz N, Zeynalova S, Blood: The Journal of the American Society of Hematology . 2009 ,第17期

机译：使用或不使用利妥昔单抗的现代化疗（CHOP-14）治疗的老年侵袭性淋巴瘤患者的中枢神经系统事件：德国高级别非霍奇金淋巴瘤研究组（DSHNHL）RICOVER-60试验中治疗患者的分析。
3. Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). [J] . Zwick C, Birkmann J, Peter N, Annals of hematology . 2008 ,第9期

机译：推注和依托泊苷的等效毒性：德国高级别非霍奇金淋巴瘤研究组（DSHNHL）使用CEMP方案（顺铂，依托泊苷，米托蒽醌）治疗顽固性或复发性侵袭性非霍奇金淋巴瘤的老年患者的多中心随机试验结果和泼尼松）。
4. EXAMINATION OF SICKNESS BEHAVIOUR IN DOGS WITH LYMPHOMA BEING TREATED WITH CHOP CHEMOTHERAPY - A PILOT STUDY [C] . J. Paul Woods, Tanya Sparling, Janet Higginson, Annual conference of the Veterinary Cancer Society . 2008

机译：淋巴瘤患者患者患者治疗斩波化疗 - 试验研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial [O] . A. Kühnl, D. Cunningham, N. Counsell, -1

机译：R-CHOP治疗的老年弥漫性大B细胞淋巴瘤患者的结果：英国NCRI R-CHOP14v21试验的结果结合分子特征分析和DSHNHL RICOVER-60试验
7. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL) [O] . W Klapper, H Stoecklein, S Zeynalova, 2008

机译：影响MYC基因座的结构像差表明预后不受德国高级非霍奇金淋巴瘤淋巴瘤研究组（DSHNHL）的随机试验中的弥漫性大B细胞淋巴瘤中的临床风险因素

High-dose CHOP plus etoposide (MegaCHOEP) in T-cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

摘要

著录项

相似文献

相关主题

期刊订阅